Shilanski & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Shilanski & Associates's JNJ Position: Q3 2025 in Review
Shilanski & Associates reduced its Johnson & Johnson (JNJ) stake by 0.13% in Q3 2025, selling an estimated $514 and leaving 2,260 shares worth $419K. The position accounts for 0.11% of the portfolio, ranked #69.
Shilanski & Associates first reported a position in JNJ in Q2 2019 and has held it in 21 quarters since. The position peaked at $586K in Q3 2022. 4,195 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.
- Shilanski & Associates held 2,260 shares of Johnson & Johnson worth $419K as of Q3 2025.
- Shilanski & Associates sold 3 Johnson & Johnson shares in Q3 2025, an estimated $514.
- Johnson & Johnson made up 0.11% of Shilanski & Associates's portfolio in Q3 2025, its #69 holding.
- Shilanski & Associates first reported a position in Johnson & Johnson in Q2 2019 and has held it in 21 quarters since.
- Shilanski & Associates's Johnson & Johnson position peaked at $586K in Q3 2022.
- 4,195 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.
Based on Shilanski & Associates's 13F filing for Q3 2025, filed 20 Oct 2025.